Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.6%

23 terminated/withdrawn out of 1398 trials

Success Rate

91.5%

+4.9% vs industry average

Late-Stage Pipeline

14%

191 trials in Phase 3/4

Results Transparency

4%

10 of 247 completed trials have results

Key Signals

282 recruiting10 with results9 terminated14 withdrawn

Enrollment Performance

Analytics

N/A
349(36.8%)
Phase 2
243(25.6%)
Phase 4
131(13.8%)
Phase 1
88(9.3%)
Early Phase 1
78(8.2%)
Phase 3
60(6.3%)
949Total
N/A(349)
Phase 2(243)
Phase 4(131)
Phase 1(88)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1398)

Showing 20 of 1398 trials
NCT06963008Early Phase 1Active Not Recruiting

A Prospective, Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) in Chinese Adults With Cystic Fibrosis

Role: lead

NCT07485543Early Phase 1Recruiting

Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

Role: lead

NCT07540286Phase 2Suspended

A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

Role: lead

NCT07530705Phase 1Suspended

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

Role: lead

NCT07835893Phase 2Recruiting

Lenvatinib Plus Chemotherapy for pNET Liver Metastases

Role: lead

NCT07835906Phase 1Not Yet Recruiting

68Ga-NYM215 in NENs

Role: lead

NCT07835880Phase 1Not Yet Recruiting

[18F]FIDT-10b PET Imaging in Cardiac Amyloidosis

Role: lead

NCT07582731Not ApplicableRecruiting

A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

Role: collaborator

NCT07829705Phase 2Recruiting

Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA

Role: lead

NCT02389400Phase 2Completed

Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

Role: lead

NCT06023784Not ApplicableRecruiting

The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block

Role: lead

NCT06411678Early Phase 1Recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Role: lead

NCT07197450Early Phase 1Suspended

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

Role: lead

NCT05575661Completed

Correlation Between Postprandial Hypotension and Post-induction Hypotension in the Elderly.

Role: lead

NCT07200141Phase 2Recruiting

Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer

Role: lead

NCT07639177Phase 2Recruiting

Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis

Role: lead

NCT06849908Phase 2Recruiting

Baricitinib in the Treatment of Intestinal Behçet's Syndrome

Role: lead

NCT07822347Phase 1Enrolling By Invitation

Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors

Role: lead

NCT04578769Not ApplicableCompleted

Assessment of Different Modified POEM for Achalasia

Role: lead

NCT06513416Completed

Gut Microbiota and Pulmonary Complications After Non Cardiac Elective Surgery in Elderly Patients

Role: lead